Abonnement à la biblothèque: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publication de 6  numéros par an

ISSN Imprimer: 1045-4403

ISSN En ligne: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Accéder(open in a new tab)
Suite
Achat $65.00(open in a new tab) Vérifier l'abonnement Télécharger l'archive MARC(open in a new tab) Obtenir des autorisations(open in a new tab)

Circadian Rhythms and Cancer Chemotherapy

Volume 6, Numéro 4, 1996, pp. 299-343
DOI: 10.1615/CritRevEukarGeneExpr.v6.i4.10
Get accessGet access
Patricia A. Wood
Oncology Service, Department of Veterans Affairs, Columbia VA Medical Center, Columbia, SC, USA
William J. M. Hrushesky
Stratton Veterans Affairs Medical Center and Albany Medical College, Albany, NY 12208

RÉSUMÉ

Temporal coordination of biologic processes with an approximately 24-h cycle (circadian) is common throughout the animal and plant kingdom and even in some prokaryotic organisms. In all organisms studied, the capability to keep biologic time is an inherited characteristic located intracellularly. These biological clocks anticipate and get the organism ready for regular environmental changes. This indicates both the ubiquity and the weight of the selective environmental pressure to keep time accurately. Several molecular strategies for biologic time keeping have apparently arisen independently several times throughout evolution. The anatomic, biochemical, and molecular mechanisms of the clock are in the process of being defined. This temporal organization at the cellular, organ, and organismic levels results in predictable differences in the capacity of plants, animals, and human beings to respond to therapeutic interventions administered at different times throughout important biologic cycles (e.g., circadian timed therapy). In the treatment of the cancer bearing host, circadian timing of surgery, anticancer drugs, radiation therapy, and biologic agents can result in improved toxicity profiles, enhanced tumor control, and improved host survival. The routine clinical application of such principles is facilitated by the availability of programmable drug delivery devices. Rhythm frequency ranges other than 24-h (e.g., low frequency: menstrual; high frequency: 10 to 120 min) may also be important to understanding health and disease and to designing successful therapy in diseases as diverse as cancer, infertility, and diabetes.

MOTS CLÉS: Circadian, cander chemotherapy, therapeutic index, biochemical pharmacology, cytokinetics, drug delivery, cytokines and growth factors.
CITÉ PAR

  1. Lincoln David W., Hrushesky William J.M., Wood Patricia A., Circadian organization of thymidylate synthase activity in normal tissues: A possible basis for 5-fluorouracil chronotherapeutic advantage, International Journal of Cancer, 88, 3, 2000. Crossref

  2. Burns E. Robert, Biological time andin vivo research: A field guide to pitfalls, The Anatomical Record, 261, 4, 2000. Crossref

  3. Hrushesky William J. M., Lannin Donald, Haus Erhard, Evidence for an Ontogenetic Basis for Circadian Coordination of Cancer Cell Proliferation, JNCI: Journal of the National Cancer Institute, 90, 19, 1998. Crossref

  4. ANCOLI-ISRAEL S., MOORE P.J., JONES V., The relationship between fatigue and sleep in cancer patients: a review, European Journal of Cancer Care, 10, 4, 2001. Crossref

  5. Elkum Naser B., Myles James D., Kumar Pranesh, Analyzing biological rhythms in clinical trials, Contemporary Clinical Trials, 29, 5, 2008. Crossref

  6. Scheving Lawrence A., Biological clocks and the digestive system, Gastroenterology, 119, 2, 2000. Crossref

  7. Jung-Hynes Brittney, Reiter Russel J., Ahmad Nihal, Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer, Journal of Pineal Research, 48, 1, 2010. Crossref

  8. Sassa Motoki, Koyama Yoshihisa, Higashimoto Masashi, Ono Koichiro, Yoshimoto Nobuhiro, Momma Tomoyuki, Saito Masaru, Ando Jin, Noda Masaru, Miyamoto Kotaro, Kobayashi Yusuke, Sugeno Hidekazu, Ishigame Teruhide, Fujita Shotaro, Ito Testuro, Sakamoto Wataru, Abe Noriko, Iwadate Manabu, Yoshida Tuneyuki, Ohshima Takasi, Takebayashi Yuji, Takenoshita Seiichi, Presence of Circadian oscillation of Multidrug Resistance Gene 1 in KB-C2 cell line, Annals of Cancer Research and Therapy, 18, 1, 2010. Crossref

  9. Fiorentino Lavinia, Ancoli-Israel Sonia, Sleep dysfunction in patients with cancer, Current Treatment Options in Neurology, 9, 5, 2007. Crossref

  10. Yang X., Wood P. A., Ansell C. M., Ohmori M., Oh E.-Y., Xiong Y., Berger F. G., Pena M. M. O., Hrushesky W. J.M.,  -Catenin Induces  -TrCP-Mediated PER2 Degradation Altering Circadian Clock Gene Expression in Intestinal Mucosa of ApcMin/+ Mice, Journal of Biochemistry, 145, 3, 2009. Crossref

  11. Kerr Leslie R., Hundal Rajinder, Silva W. André, Emerman Joanne T., Weinberg Joanne, Effects of Social Housing Condition on Chemotherapeutic Efficacy in a Shionogi Carcinoma (SC115) Mouse Tumor Model: Influences of Temporal Factors, Tumor Size, and Tumor Growth Rate, Psychosomatic Medicine, 63, 6, 2001. Crossref

  12. Fiorentino Lavinia, Ancoli-Israel Sonia, Sleep dysfunction in patients with cancer, Current Treatment Options in Neurology, 9, 5, 2007. Crossref

  13. Yang Xiaoming, Wood Patricia A., Oh Eun-Young, Du-Quiton Jovelyn, Ansell Christine M., Hrushesky William J. M., Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm, Breast Cancer Research and Treatment, 117, 2, 2009. Crossref

  14. Hrushesky W.J.M., Tumor chronobiology, Journal of Controlled Release, 74, 1-3, 2001. Crossref

  15. Youan Bi-Botti C., Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?, Journal of Controlled Release, 98, 3, 2004. Crossref

  16. Ancoli-Israel Sonia, Sleep and Fatigue in Cancer Patients, in Principles and Practice of Sleep Medicine, 2005. Crossref

  17. Wille John J., Circadian rhythm of tumor promotion in the two-stage model of mouse tumorigenesis, Cancer Letters, 190, 2, 2003. Crossref

  18. Zorzet Sonia, Perissin Laura, Rapozzi Valentina, Giraldi Tullio, Seasonal Dependency of the Effects of Rotational Stress and Cyclophosphamide in Mice Bearing Lewis Lung Carcinoma, Brain, Behavior, and Immunity, 16, 4, 2002. Crossref

  19. Block Keith I., Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States, Chronobiology International, 19, 1, 2002. Crossref

  20. Khedhaier Achraf, Ben‐Attia Mossadok, Gadacha Wafa, Sani Mamane, Reinberg Alain, Boughattas Naceur A., Seasonal Modulation of the 8‐and 24‐Hour Rhythms of Ondansetron Tolerance in Mice, Chronobiology International, 24, 6, 2007. Crossref

  21. Mehling Annette, Reymermier Corinne, Chronobiology of the Skin: Cutaneous Clocks and Biorhythms, in Agache's Measuring the Skin, 2017. Crossref

  22. Scheving Lawrence A., Gardner Wendi, Circadian regulation of CREB transcription factor in mouse esophagus, American Journal of Physiology-Cell Physiology, 274, 4, 1998. Crossref

  23. Reid Fiona, Renal System, in Pediatric Oncology Nursing, 22, 2005. Crossref

  24. You Shaojin, Wood Patricia A., Xiong Yin, Kobayashi Minoru, Du-Quiton Jovelyn, Hrushesky William J. M., Daily coordination of cancer growth and circadian clock gene expression, Breast Cancer Research and Treatment, 91, 1, 2005. Crossref

  25. Reid Fiona, Renal System, in Pediatric Oncology Nursing, 2010. Crossref

  26. Mehling Annette, Reymermier Corinne, Chronobiology of the Skin: Cutaneous Clocks and Biorhythms, in Measuring the Skin, 2015. Crossref

  27. Damiens Eve, Molecular events that regulate cell proliferation: an approach for the development of new anticancer drugs, in Progress in Cell Cycle Research, 2000. Crossref

  28. Kliche K. O., von Roemeling R. W., Chronomodulierte Chemotherapie, in Kompendium Internistische Onkologie, 2006. Crossref

  29. Wang Shuai, Lin Yanke, Gao Lu, Yang Zemin, Dong Dong, Role of Non-Pharmacokinetic Factors in Chronoefficacy, in Circadian Pharmacokinetics, 2020. Crossref

  30. Vitalini Michael W., Dunlap Jay C., Heintzen Christian, Liu Yi, Loros Jennifer, Bell-Pedersen Deborah, Circadian Rhythms, in Cellular and Molecular Biology of Filamentous Fungi, 2014. Crossref

  31. Gallion Holly H., Brunetto Virginia L., Cibull Michael, Lentz Samuel S., Reid Gary, Soper John T., Burger Robert A., Andersen Willie, Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study, Journal of Clinical Oncology, 21, 20, 2003. Crossref

  32. Liu Lianqi, Ancoli-Israel Sonia, Sleep and its disorders: clinical science, in Cancer Symptom Science, 2010. Crossref

  33. Fu Loning, Lee Cheng Chi, The circadian clock: pacemaker and tumour suppressor, Nature Reviews Cancer, 3, 5, 2003. Crossref

  34. Kamarck Thomas W., al’Absi Mustafa, Epstein David, Ertin Emre, Intille Stephen, Kirk Gregory, Kumar Santosh, Preston Kenzie L., Rea Mark, Shetty Vivek, Shiffman Saul, Siewiorek Dan, Smailagic Asim, Stone Clem, Venugopal Manju, Ambulatory Monitoring and Ecological Momentary Assessment, in Handbook of Cardiovascular Behavioral Medicine, 2022. Crossref

929 Vues d'articles 15 Téléchargements d'articles Métrique
929 VUES 15 TÉLÉCHARGEMENTS 34 Crossref CITATIONS Google
Scholar CITATIONS

Articles avec un contenu similaire:

Role of Toll-Like Receptors in Hepatitis C Virus Pathogenesis and Treatment Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 4
Saba Khaliq, Usman Ali Ashfaq, Muhammad Sarfaraz Iqbal
Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer Journal of Environmental Pathology, Toxicology and Oncology, Vol.42, 2023, issue 4
Md. Abubakar, Ahsas Goyal, V. G. M. Naidu, Gaurav Gupta, Vetriselvan Subramaniyan, Waleed Hassan Almalki, Ch. Veera Bhadrawamy, S. Roshan, Fahim Anwar Rizwi, Sushama Rawat, Eswara Rao Puppala, B. Tazneem
Phosphorylation Signaling in Mycobacterium Tuberculosis: An Overview Onco Therapeutics, Vol.6, 2015, issue 3-4
Angela C. O. Menegatti, Hernan Terenzi
Insights into Oncogenesis from Circadian Timing in Cancer Stem Cells Critical Reviews™ in Oncogenesis, Vol.26, 2021, issue 4
Astha Malik, Michael Eric Geusz, Arpan De
Oscillation Mechanics of the Respiratory System: Applications to Lung Disease Critical Reviews™ in Biomedical Engineering, Vol.39, 2011, issue 4
Raffaele L. Dellaca, David Kaczka

Dernier numéro

SIAH2-Mediated Degradation of ACSL4 Inhibits the Anti-Tumor Activity of CD8+ T Cells in Hepatocellular Carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer Ruixue Wang, Wenhua Tan SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH1 Promotes the Pyroptosis of Cardiomyocytes in Diabetic Cardiomyopathy via Regulating IκB-α/NF-κВ Signaling Jinbin Wu, Yaoming Yan PURPL Promotes M2 Macrophage Polarization in Lung Cancer by Regulating RBM4/xCT Signaling Jipeng Guo, Chongwen Gong, Hao Wang

Prochains articles

Fundamentals and translational applications of stem cells and biomaterials in dental, oral and craniofacial regenerative medicine Yasaman Daneshian, Eric Lewallen, Amr Badreldin, Allan Dietz , Gary Stein, Simon Cool, Hyun-Mo Ryoo, Young Dan Cho, Andre van Wijnen Inflammatory Markers Involved in the Pathogenesis of Dupuytren Contracture William Cates, Janet Denbeigh, Ralph Salvagno, Sanjeev Kakar, Andre van Wijnen, Charles Eaton PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain